Ali Dehghani Firoozabadi
Overview
Explore the profile of Ali Dehghani Firoozabadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghasemzadeh N, Pourrajab F, Dehghani Firoozabadi A, Rahnama M
Iran Biomed J
. 2025 Feb;
28(5 & 6):245-54.
PMID: 39891467
Background: Developing miRNA-mediated cell engineering introduces a novel technology for cell reprogramming and generating patient-specific tissues for therapeutic use, facilitating basic research on human adult stem cells. Furthermore, optimizing a...
2.
Mozafari S, Ashoori M, Meybodi S, Solhi R, Reza Mirjalili S, Dehghani Firoozabadi A, et al.
BMC Genomics
. 2024 Jun;
25(1):590.
PMID: 38867151
Background: The association between Apolipoprotein A5 (APOA5) genetic polymorphisms and susceptibility to metabolic syndrome (MetS) has been established by many studies, but there have been conflicting results from the literature....
3.
Meybodi S, Moraddahande F, Dehghani Firoozabadi A
Heliyon
. 2024 May;
10(9):e29858.
PMID: 38698968
Background And Aims: Glioblastoma (GBM) is an aggressive primary brain cancer with no promising curative therapies. It has been indicated that MSCs can interact with the tumour microenvironment (TME) through...
4.
Asadollahi S, Hadizadeh M, Namiranian N, Kalantar S, Dehghani Firoozabadi A, Injinari N
Gene
. 2023 Feb;
862:147265.
PMID: 36764337
Aims: Currently, diabetic nephropathy (DN) is considered the leading cause of the end-stage renal disease (ESRD). However, its specific molecular mechanism is still unclear, and there is still a lack...
5.
Meybodi S, Soleimani N, Yari A, Javadifar A, Tollabi M, Karimi B, et al.
Int J Biol Macromol
. 2022 Nov;
225:1049-1071.
PMID: 36414082
Cardiovascular diseases (CVDs) are a group of disorders with major global health consequences. The prevalence of CVDs continues to grow due to population-aging and lifestyle modifications. Non-coding RNAs (ncRNAs) as...
6.
Karimi B, Dehghani Firoozabadi A, Peymani M, Ghaedi K
Hum Immunol
. 2022 Jun;
83(8-9):618-627.
PMID: 35717260
Long non-coding RNAs (lncRNAs) are an emerging class of non-coding RNAs that do not encode proteins. These RNAs have various essential regulatory functions. Irregular expression of lncRNAs has been related...
7.
Ghazizadeh E, Neshastehriz A, Dehghani Firoozabadi A, Yazdi M, Saievar-Iranizad E, Einali S
Sci Rep
. 2021 Nov;
11(1):22969.
PMID: 34836981
It has been necessary to use methods that can detect the specificity of a virus during virus screening. In this study, we use a dual platform to identify any spiked...
8.
Ghaffari M, Kalantar S, Hemati M, Dehghani Firoozabadi A, Asri A, Shams A, et al.
Biotechnol Lett
. 2021 Jan;
43(5):981-994.
PMID: 33515341
Objective: Tumor suppressor miRNAs, miR-15a and miR-16-1, with high-specificity and oncogenic targeting of Bcl-2, can target tumor tissues. Disadvantages of the clinical application of free miRNAs include poor cellular uptake...
9.
Hossein Razi M, Eftekhar M, Ghasemi N, Sheikhha M, Dehghani Firoozabadi A
Int J Reprod Biomed
. 2020 Jul;
18(5):347-358.
PMID: 32637863
Background: Using blood-based biomarkers such as microRNAs (miRNAs) may allow particularly effective and minimally invasive diagnosis and treatment of endometriosis. We evaluated the differential expression of circulating miRNA-185-5p (miR-185-5p), vascular...
10.
Hosseinabadi O, Behnam M, Khoradmehr A, Emami F, Sobhani Z, Dehghanian A, et al.
Biomed Pharmacother
. 2020 Apr;
127:110118.
PMID: 32244195
Objective: In the current study we have stimulated the efficacy of plasmonic nanoparticles (NPs) by laser hyperthermia to achieve a less invasive method for tumor photothermal therapy of benign prostatic...